PubMed:1832547
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 36-56 | protein | denotes | serum immunoglobulin |
| T2 | 133-168 | cell_type | denotes | immunoglobulin (Ig)-secreting cells |
| T3 | 172-225 | cell_line | denotes | pokeweed mitogen (PWM)-stimulated lymphocyte cultures |
| T4 | 227-238 | cell_type | denotes | Lymphocytes |
| T5 | 321-339 | cell_type | denotes | Ig-secreting cells |
| T6 | 346-349 | protein | denotes | PWM |
| T7 | 429-449 | protein | denotes | serum immunoglobulin |
| T8 | 451-454 | protein | denotes | IgA |
| T9 | 456-459 | protein | denotes | IgM |
| T10 | 461-464 | protein | denotes | IgG |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-81 | Sentence | denotes | The effect of toremifene therapy on serum immunoglobulin levels in breast cancer. |
| S2 | 82-226 | Sentence | denotes | Estrogens and anti-estrogens enhance the number of immunoglobulin (Ig)-secreting cells in pokeweed mitogen (PWM)-stimulated lymphocyte cultures. |
| S3 | 227-362 | Sentence | denotes | Lymphocytes from patients who have received anti-estrogen therapy show similar enhancement of Ig-secreting cells after PWM stimulation. |
| S4 | 363-516 | Sentence | denotes | In this study the effect of anti-estrogen (toremifene) therapy on serum immunoglobulin (IgA, IgM, IgG) levels in breast cancer patients was investigated. |
| S5 | 517-591 | Sentence | denotes | Serum Ig levels were followed up to two years after or during the therapy. |
| S6 | 592-675 | Sentence | denotes | An unexpected finding was that the Ig levels decreased during the follow-up period. |
| S7 | 676-772 | Sentence | denotes | This decrease was seen in patients who responded to the therapy as well as in those who did not. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 14-32 | NP | denotes | toremifene therapy |
| C2 | 36-63 | NP | denotes | serum immunoglobulin levels |
| C3 | 67-80 | NP | denotes | breast cancer |
| C4 | 96-110 | NP | denotes | anti-estrogens |
| C5 | 133-168 | NP | denotes | immunoglobulin (Ig)-secreting cells |
| C6 | 172-225 | NP | denotes | pokeweed mitogen (PWM)-stimulated lymphocyte cultures |
| C7 | 244-252 | NP | denotes | patients |
| C8 | 253-256 | NP | denotes | who |
| C10 | 271-284 | NP | denotes | anti-estrogen |
| C9 | 271-292 | NP | denotes | anti-estrogen therapy |
| C11 | 321-339 | NP | denotes | Ig-secreting cells |
| C12 | 346-361 | NP | denotes | PWM stimulation |
| C14 | 391-404 | NP | denotes | anti-estrogen |
| C13 | 391-425 | NP | denotes | anti-estrogen (toremifene) therapy |
| C15 | 429-472 | NP | denotes | serum immunoglobulin (IgA, IgM, IgG) levels |
| C17 | 476-489 | NP | denotes | breast cancer |
| C16 | 476-498 | NP | denotes | breast cancer patients |
| C18 | 517-532 | NP | denotes | Serum Ig levels |
| C19 | 579-590 | NP | denotes | the therapy |
| C20 | 623-636 | NP | denotes | the Ig levels |
| C21 | 702-710 | NP | denotes | patients |
| C22 | 711-714 | NP | denotes | who |
| C23 | 728-739 | NP | denotes | the therapy |
| C24 | 754-759 | NP | denotes | those |
| C25 | 760-763 | NP | denotes | who |
| R1 | C8 | C7 | coref-relat | who,patients |
| R2 | C10 | C4 | coref-ident | anti-estrogen,anti-estrogens |
| R3 | C9 | C1 | coref-ident | anti-estrogen therapy,toremifene therapy |
| R4 | C11 | C5 | coref-ident | Ig-secreting cells,immunoglobulin (Ig)-secreting cells |
| R5 | C12 | C6 | coref-ident | PWM stimulation,pokeweed mitogen (PWM)-stimulated lymphocyte cultures |
| R6 | C14 | C10 | coref-ident | anti-estrogen,anti-estrogen |
| R7 | C13 | C9 | coref-ident | anti-estrogen (toremifene) therapy,anti-estrogen therapy |
| R8 | C15 | C2 | coref-ident | "serum immunoglobulin (IgA, IgM, IgG) levels",serum immunoglobulin levels |
| R9 | C17 | C3 | coref-ident | breast cancer,breast cancer |
| R10 | C16 | C7 | coref-ident | breast cancer patients,patients |
| R11 | C18 | C15 | coref-ident | Serum Ig levels,"serum immunoglobulin (IgA, IgM, IgG) levels" |
| R12 | C19 | C13 | coref-ident | the therapy,anti-estrogen (toremifene) therapy |
| R13 | C20 | C18 | coref-ident | the Ig levels,Serum Ig levels |
| R14 | C21 | C16 | coref-ident | patients,breast cancer patients |
| R15 | C22 | C21 | coref-relat | who,patients |
| R16 | C23 | C19 | coref-ident | the therapy,the therapy |
| R17 | C24 | C21 | coref-pron | those,patients |
| R18 | C25 | C24 | coref-relat | who,those |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-24 | other_organic_compound | denotes | toremifene |
| T2 | 36-56 | protein_family_or_group | denotes | serum immunoglobulin |
| T3 | 67-80 | lipid | denotes | breast cancer |
| T4 | 82-91 | lipid | denotes | Estrogens |
| T5 | 96-110 | other_organic_compound | denotes | anti-estrogens |
| T6 | 133-168 | cell_type | denotes | immunoglobulin (Ig)-secreting cells |
| T7 | 172-188 | protein_molecule | denotes | pokeweed mitogen |
| T8 | 190-193 | protein_molecule | denotes | PWM |
| T9 | 227-238 | cell_type | denotes | Lymphocytes |
| T10 | 244-252 | multi_cell | denotes | patients |
| T11 | 271-292 | other_name | denotes | anti-estrogen therapy |
| T12 | 321-339 | cell_type | denotes | Ig-secreting cells |
| T13 | 346-349 | protein_molecule | denotes | PWM |
| T14 | 391-406 | other_name | denotes | anti-estrogen ( |
| T15 | 406-416 | other_organic_compound | denotes | toremifene |
| T16 | 429-449 | protein_family_or_group | denotes | serum immunoglobulin |
| T17 | 451-454 | protein_family_or_group | denotes | IgA |
| T18 | 456-459 | protein_domain_or_region | denotes | IgM |
| T19 | 461-464 | protein_family_or_group | denotes | IgG |
| T20 | 476-489 | multi_cell | denotes | breast cancer |
| T21 | 490-498 | multi_cell | denotes | patients |
| T22 | 517-532 | other_name | denotes | Serum Ig levels |
| T23 | 627-636 | other_name | denotes | Ig levels |
| T24 | 702-710 | multi_cell | denotes | patients |
| T25 | 732-739 | other_name | denotes | therapy |